These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27561342)

  • 1. [Point of note in the treatment of osteoporotic patients complicated with chronic kidney disease].
    Inaba M
    Clin Calcium; 2016 Sep; 26(9):1277-85. PubMed ID: 27561342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adynamic bone disease: from bone to vessels in chronic kidney disease.
    Bover J; Ureña P; Brandenburg V; Goldsmith D; Ruiz C; DaSilva I; Bosch RJ
    Semin Nephrol; 2014 Nov; 34(6):626-40. PubMed ID: 25498381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteoporosis and adynamic bone in chronic kidney disease.
    Cannata-Andía JB; Rodriguez García M; Gómez Alonso C
    J Nephrol; 2013; 26(1):73-80. PubMed ID: 23023723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Updates on Lifestyle-Related Diseases and Bone Metabolism. CKD-related osteoporosis].
    Yamada S; Inaba M
    Clin Calcium; 2014 Nov; 24(11):1605-13. PubMed ID: 25355144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoporosis management in patient with renal function impairment.
    Lima GA; Paranhos Neto Fde P; Pereira GR; Gomes CP; Farias ML
    Arq Bras Endocrinol Metabol; 2014 Jul; 58(5):530-9. PubMed ID: 25166044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiating the causes of adynamic bone in advanced chronic kidney disease informs osteoporosis treatment.
    Haarhaus M; Evenepoel P; ;
    Kidney Int; 2021 Sep; 100(3):546-558. PubMed ID: 34102219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Abnormalities Underlying Bone Fragility in Chronic Kidney Disease.
    Iwasaki Y; Kazama JJ; Fukagawa M
    Biomed Res Int; 2017; 2017():3485785. PubMed ID: 28421193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to predict and treat increased fracture risk in chronic kidney disease.
    West SL; Patel P; Jamal SA
    J Intern Med; 2015 Jul; 278(1):19-28. PubMed ID: 25758353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic kidney disease and fragility fracture.
    Kazama JJ
    Clin Exp Nephrol; 2017 Mar; 21(Suppl 1):46-52. PubMed ID: 28012057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review and perspective on the assessment, management and prevention of fragility fractures in patients with osteoporosis and chronic kidney disease.
    Hampson G; Elder GJ; Cohen-Solal M; Abrahamsen B
    Endocrine; 2021 Sep; 73(3):509-529. PubMed ID: 33974225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". CKD and osteoporosis].
    Yamada S; Inaba M
    Clin Calcium; 2015 Sep; 25(9):1329-38. PubMed ID: 26320533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series.
    Amerling R; Harbord NB; Pullman J; Feinfeld DA
    Blood Purif; 2010; 29(3):293-9. PubMed ID: 20090316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventive Strategies for Vascular Calcification in Patients with Chronic Kidney Disease.
    Shigematsu T; Sonou T; Ohya M; Yokoyama K; Yoshida H; Yokoo T; Okuda K; Masumoto AR; Iwashita Y; Iseki K; Kunimoto S; Yamano Y
    Contrib Nephrol; 2017; 189():169-177. PubMed ID: 27951564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractures in chronic kidney disease: pursuing the best screening and management.
    Goldenstein PT; Jamal SA; Moysés RM
    Curr Opin Nephrol Hypertens; 2015 Jul; 24(4):317-23. PubMed ID: 26050117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis, bone mineral density and CKD-MBD complex (I): Diagnostic considerations.
    Bover J; Ureña-Torres P; Torregrosa JV; Rodríguez-García M; Castro-Alonso C; Górriz JL; Laiz Alonso AM; Cigarrán S; Benito S; López-Báez V; Lloret Cora MJ; daSilva I; Cannata-Andía J
    Nefrologia (Engl Ed); 2018; 38(5):476-490. PubMed ID: 29703451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBDs): What the Endocrinologist Needs to Know.
    Zangeneh F; Clarke BL; Hurley DL; Watts NB; Miller PD
    Endocr Pract; 2014 May; 20(5):500-16. PubMed ID: 24325991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bone-Vascular Axis in Chronic Kidney Disease: From Pathophysiology to Treatment.
    Vachey C; Candellier A; Toutain S; Mac-Way F
    Curr Osteoporos Rep; 2024 Feb; 22(1):69-79. PubMed ID: 38195897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease mineral bone disorder in childhood and young adulthood: a 'growing' understanding.
    Lalayiannis AD; Soeiro EMD; Moysés RMA; Shroff R
    Pediatr Nephrol; 2024 Mar; 39(3):723-739. PubMed ID: 37624528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.